FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 57 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2017. The put-call ratio across all filers is 21.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $148,000 | -17.8% | 29,600 | -15.7% | 0.01% | 0.0% |
| Q1 2018 | $180,000 | -9.1% | 35,100 | +6.7% | 0.01% | 0.0% |
| Q4 2017 | $198,000 | -27.7% | 32,900 | -33.3% | 0.01% | -33.3% |
| Q3 2017 | $274,000 | -9.9% | 49,300 | -24.7% | 0.01% | -25.0% |
| Q2 2017 | $304,000 | -28.6% | 65,500 | +12.8% | 0.01% | +20.0% |
| Q3 2015 | $426,000 | -29.8% | 58,052 | -2.0% | 0.01% | -37.5% |
| Q2 2015 | $607,000 | – | 59,236 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $28,738,000 | 4.90% |
| DSC Advisors, L.P. | 1,187,604 | $7,138,000 | 4.14% |
| Opaleye Management Inc. | 960,000 | $5,769,000 | 1.85% |
| DAFNA Capital Management LLC | 352,741 | $2,120,000 | 1.14% |
| Vivo Capital, LLC | 855,000 | $5,139,000 | 1.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 382,838 | $2,301,000 | 0.81% |
| SENZAR ASSET MANAGEMENT, LLC | 377,397 | $2,268,000 | 0.58% |
| Sio Capital Management, LLC | 131,200 | $789,000 | 0.44% |
| Perceptive Advisors | 1,117,324 | $6,715,000 | 0.22% |
| Tekla Capital Management LLC | 930,398 | $5,592,000 | 0.22% |